We report a 61-year-old 
Introduction

Familial amyloid polyneuropathy (FAP) is a group of autosomal dominant disorders caused by a mutant transthyretin (TTR). It is characterized by peripheral neuropathy, autonomic dysfunction, and the involvement of vital organs. About 100 different disease-causing mutations of the TTR have been reported (1-4). Since both normal and variant TTR are synthesized by the liver, liver transplantation is now the only way to control disease progression. TTR Met30 FAP (FAP type I) is the most common type of familial polyneuropathy in Japan, and is characterized by early onset, a high penetrance rate, marked autonomic dysfunction, and steady disease progression (5-7). Other major types
. The prevalence of vitreous opacities is much higher in patients with ATTR Tyr114Cys (100%) than in those with ATTR Val30Met (24%) and is 0% within 5 to 10 years, and 17% at 10 years and later (17) . Vitreous amyloid deposits can be the first indication of disease (14, 15) 
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